LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 108 filers reported holding LEXICON PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 2.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $20,908 | -30.0% | 12,445 | 0.0% | 0.00% | -33.3% |
Q1 2024 | $29,868 | +56.9% | 12,445 | 0.0% | 0.00% | +50.0% |
Q4 2023 | $19,041 | +44.0% | 12,445 | +2.6% | 0.00% | 0.0% |
Q3 2023 | $13,227 | -52.4% | 12,135 | 0.0% | 0.00% | -33.3% |
Q2 2023 | $27,789 | +0.4% | 12,135 | +6.6% | 0.00% | -25.0% |
Q1 2023 | $27,666 | +39.0% | 11,385 | +9.3% | 0.00% | +33.3% |
Q4 2022 | $19,902 | -17.1% | 10,420 | +2.8% | 0.00% | -25.0% |
Q3 2022 | $24,000 | – | 10,140 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ulys, L.L.C. | 4,321,214 | $42,694,000 | 100.00% |
Artal Group S.A. | 58,274,650 | $575,754,000 | 8.68% |
SECTOR GAMMA AS | 837,192 | $8,271,000 | 1.39% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $353,000 | 1.36% |
Virtus ETF Advisers LLC | 95,079 | $939,000 | 1.18% |
NEA Management Company, LLC | 2,382,286 | $23,537,000 | 0.98% |
USS Investment Management Ltd | 3,507,900 | $34,676,000 | 0.40% |
Malaga Cove Capital, LLC | 59,387 | $587,000 | 0.33% |
CLEARBRIDGE, LLC | 1,189,097 | $11,748,000 | 0.24% |
WEDBUSH SECURITIES INC | 139,106 | $1,374,000 | 0.17% |